Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis

Almost all the patients with hepatocellular carcinoma (HCC) at advanced stage experience pathological changes of chronic liver cirrhosis, which generally leads to moderate ascites. Recognition of novel biomarkers in malignant ascites could be favorable for establishing a diagnosis for the HCC patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinyan, Liang, Rong, Wei, Jiazhang, Ye, Jiaxiang, He, Qian, ChunlingYuan, Ye, Jiazhou, Li, Yongqiang, Liu, Zhihui, Lin, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174818/
https://www.ncbi.nlm.nih.gov/pubmed/30345303
http://dx.doi.org/10.1155/2018/5484976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174818/
https://www.ncbi.nlm.nih.gov/pubmed/30345303
http://dx.doi.org/10.1155/2018/5484976

Ejemplares similares